ETSELBA

Serial Number 97127061
732

Registration Progress

Application Filed
Nov 16, 2021
Under Examination
Aug 15, 2023
Approved for Publication
Jun 20, 2023
Published for Opposition
Jun 20, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 3 Granted
Due: Aug 15, 2025 13 days

Trademark Image

ETSELBA

Basic Information

Serial Number
97127061
Filing Date
November 16, 2021
Published for Opposition
June 20, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
Feb 14, 2025
Application
Pending
Classes
005

Rights Holder

Sun Pharma Advanced Research Company Limited

16
Address
17/B, Mahal Industrial Estate
Mahakali Caves Road, Andheri (East)
Mumbai 400093
IN

Ownership History

Sun Pharma Advanced Research Company Limited

Original Applicant
16
Mumbai IN

Sun Pharma Advanced Research Company Limited

Owner at Publication
16
Mumbai IN

Legal Representation

Attorney
Craig Kuchii

USPTO Deadlines

Next Deadline
13 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
August 15, 2025
Extension Available
Until August 15, 2024

Application History

26 events
Date Code Type Description Documents
Feb 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 14, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 14, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 14, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 8, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 8, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 8, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 8, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 14, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 13, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 13, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 13, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 15, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 20, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 20, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 31, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 18, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 7, 2023 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Feb 7, 2023 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Feb 7, 2023 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Aug 10, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Aug 10, 2022 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Aug 10, 2022 CNSL R SUSPENSION LETTER WRITTEN Loading...
Aug 9, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 22, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 19, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of ophthalmic diseases and disorders

Classification

International Classes
005